These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9389531)
1. The role of the active site cysteine in catalysis by type 1 iodothyronine deiodinase. Sun BC; Harney JW; Berry MJ; Larsen PR Endocrinology; 1997 Dec; 138(12):5452-8. PubMed ID: 9389531 [TBL] [Abstract][Full Text] [Related]
2. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase. Borges M; Ingbar SH; Silva JE Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108 [TBL] [Abstract][Full Text] [Related]
3. Deiodination of thyroid hormone by human liver. Visser TJ; Kaptein E; Terpstra OT; Krenning EP J Clin Endocrinol Metab; 1988 Jul; 67(1):17-24. PubMed ID: 3379132 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Toyoda N; Kaptein E; Berry MJ; Harney JW; Larsen PR; Visser TJ Endocrinology; 1997 Jan; 138(1):213-9. PubMed ID: 8977406 [TBL] [Abstract][Full Text] [Related]
5. Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2002 Apr; 143(4):1190-8. PubMed ID: 11897672 [TBL] [Abstract][Full Text] [Related]
6. Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Mol JA; Visser TJ Endocrinology; 1985 Jul; 117(1):8-12. PubMed ID: 4006868 [TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the substrate selectivity of cat type I iodothyronine deiodinase. Kuiper GG; Wassen F; Klootwijk W; Van Toor H; Kaptein E; Visser TJ Endocrinology; 2003 Dec; 144(12):5411-21. PubMed ID: 12960017 [TBL] [Abstract][Full Text] [Related]
8. Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. Visser TJ; Kaplan MM; Leonard JL; Larsen PR J Clin Invest; 1983 Apr; 71(4):992-1002. PubMed ID: 6833498 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase. Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ Endocrinology; 1997 Dec; 138(12):5153-60. PubMed ID: 9389495 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an iodothyronine 5'-deiodinase in gilthead seabream (Sparus auratus) that is inhibited by dithiothreitol. Klaren PH; Haasdijk R; Metz JR; Nitsch LM; Darras VM; Van der Geyten S; Flik G Endocrinology; 2005 Dec; 146(12):5621-30. PubMed ID: 16166227 [TBL] [Abstract][Full Text] [Related]
11. Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Berry MJ; Maia AL; Kieffer JD; Harney JW; Larsen PR Endocrinology; 1992 Oct; 131(4):1848-52. PubMed ID: 1396330 [TBL] [Abstract][Full Text] [Related]
12. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. Mandel SJ; Berry MJ; Kieffer JD; Harney JW; Warne RL; Larsen PR J Clin Endocrinol Metab; 1992 Oct; 75(4):1133-9. PubMed ID: 1400883 [TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast. Kuiper GG; Klootwijk W; Visser TJ J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354 [TBL] [Abstract][Full Text] [Related]
15. Rainbow trout liver expresses two iodothyronine phenolic ring deiodinase pathways with the characteristics of mammalian types I and II 5'-deiodinases. Orozco A; Silva JE; Valverde-R C Endocrinology; 1997 Jan; 138(1):254-8. PubMed ID: 8977411 [TBL] [Abstract][Full Text] [Related]
16. Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver. Rutgers M; Heusdens FA; Visser TJ Endocrinology; 1991 Sep; 129(3):1375-81. PubMed ID: 1874177 [TBL] [Abstract][Full Text] [Related]
17. Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2003 Jun; 144(6):2505-13. PubMed ID: 12746313 [TBL] [Abstract][Full Text] [Related]
18. Comparison of kidney and brown adipose tissue iodothyronine 5'-deiodinases. Silva JE; Mellen S; Larsen PR Endocrinology; 1987 Aug; 121(2):650-6. PubMed ID: 3595535 [TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil. Kuiper GG; Klootwijk W; Morvan Dubois G; Destree O; Darras VM; Van der Geyten S; Demeneix B; Visser TJ Endocrinology; 2006 Jul; 147(7):3519-29. PubMed ID: 16601143 [TBL] [Abstract][Full Text] [Related]
20. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. Campos-Barros A; Hoell T; Musa A; Sampaolo S; Stoltenburg G; Pinna G; Eravci M; Meinhold H; Baumgartner A J Clin Endocrinol Metab; 1996 Jun; 81(6):2179-85. PubMed ID: 8964848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]